Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The come-back of hypofractionation?].

Jean-Marc Cosset1

  • 1Département d'oncologie-radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris, France. jean-marc.cosset@curie.net

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|October 15, 2005
PubMed
Summary

Hypofractionation, using fewer, larger radiation doses, is re-emerging for breast and prostate cancers. While offering convenience, its efficacy and safety require further investigation through randomized trials before widespread adoption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Grandeur, delirium and polemics… the history of radium].

La Revue du praticien·2024
Same author

[Place of Linacs in extracranial stereotactic radiotherapy: Are they now equivalent to Cyberknife®?]

Bulletin du cancer·2022
Same author

Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021
Same author

COVID-19-Associated Pneumonia: Radiobiological Insights.

Frontiers in pharmacology·2021
Same author

Focal Brachytherapy for Localized Prostate Cancer: Midterm Outcomes.

Practical radiation oncology·2021
Same author

Is there any benefit to particles over photon radiotherapy?

Ecancermedicalscience·2020

Area of Science:

  • Radiation Oncology
  • Medical Physics

Background:

  • Hypofractionation, a radiotherapy technique using fewer, larger doses, has historical roots and reappeared in the 1970s.
  • Previous attempts with hypofractionation led to increased late complications, causing its abandonment except for palliative care.

Purpose of the Study:

  • To evaluate the resurgence of hypofractionation, particularly for breast and prostate cancers.
  • To assess the potential benefits and risks of hypofractionation in modern radiotherapy.

Main Methods:

  • Review of historical and recent applications of hypofractionation in radiotherapy.
  • Analysis of radiobiological data and clinical outcomes for hypofractionated schedules.
  • Examination of proposed hypofractionation schemes for breast and prostate cancer.

Related Experiment Videos

Main Results:

  • Hypofractionation is being reconsidered for breast cancer, aiming for patient and physician convenience, though efficacy/toxicity data are debated.
  • For prostate cancer, new radiobiological theories suggest higher fractionation sensitivity, leading to proposed hypofractionated schedules with preliminary comparable results.
  • Recent data challenge the presumed high fractionation sensitivity of prostate cancer, necessitating caution.

Conclusions:

  • Prudence is advised before altering established radiotherapy schedules for breast and prostate cancers.
  • Well-designed randomized trials are essential to validate new hypofractionation concepts for specific cancer types.